Glass Lewis & Co. recommended on Aug. 13 that its shareholders vote for the proposed deal. Glass Lewis & Co. is the second proxy advisory firm to support the pending transaction after Institutional Shareholder Services backed the deal on Aug. 10. Hedge fund Glenview Capital Management, which has stake in Cigna, also backed the potential deal.
Glass Lewis said the merger would be strategically and financially advantageous for Cigna shareholders, according to the report. Shareholders are set to vote on the deal Aug. 24.
More articles on payers:
8 recent payer-provider disputes, resolutions
Humana divests $2.4B long-term insurance business
Risk adjustment payments to be based on 2018 premiums, CMS proposes
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.